# Electroconvulsive Therapy and Concomitant Lithium in Depressive Disorder: A Pilot Study

> **NCT05923476** · EARLY_PHASE1 · UNKNOWN · sponsor: **Melbourne Health** · enrollment: 20 (estimated)

## Conditions studied

- Depressive Disorder

## Interventions

- **DRUG:** Lithium

## Key facts

- **NCT ID:** NCT05923476
- **Lead sponsor:** Melbourne Health
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06-01
- **Primary completion:** 2025-05-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05923476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05923476, "Electroconvulsive Therapy and Concomitant Lithium in Depressive Disorder: A Pilot Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05923476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*